IDEXX Laboratories insider trading
IDXXfinancial statementsForm 4 filings on EDGAR231 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at IDEXX Laboratories bought $0 of stock in the open market, and 1 sold $1M. Officers and directors accounted for $0 of purchases and $1M of sales. The last reported transaction was an option exercise by Kingsley Lawrence D on September 4, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through September 9, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $1MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
231 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Kingsley Lawrence D | Director | option exercise | 2,203 | $114.17 | $252K | 11,771 | Sep 9, 2026 |
| Sep 4, 2026 | Kingsley Lawrence D | Director | open-market sale | 2,203 | $532.08 | $1M | 9,568 | Sep 9, 2026 |
| Aug 20, 2026 | Emerson Andrew | EVP, CFO and Treasurer | option exercise | 265 | $178.26 | $47K | 4,507 | Aug 24, 2026 |
| Aug 20, 2026 | Emerson Andrew | EVP, CFO and Treasurer | tax withholding | 86 | $0.00 | — | 4,421 | Aug 24, 2026 |
| Jul 30, 2026 | Hooley Joseph L | Director | award | 49 | $558.80 | $27K | 325 | Aug 3, 2026 |
| Jun 1, 2026 | Fennell George | Executive Vice President | option exercise | 639 | $0.00 | — | 10,717 | Jun 2, 2026 |
| Jun 1, 2026 | Fennell George | Executive Vice President | tax withholding | 284 | $566.79 | $161K | 10,433 | Jun 2, 2026 |
| May 7, 2026 | Vandebroek Sophie V. | Director | option exercise | 257 | $0.00 | — | 905 | May 11, 2026 |
| May 7, 2026 | Szostak M Anne | Director | option exercise | 257 | $0.00 | — | 519 | May 11, 2026 |
| May 7, 2026 | Peacock Karen | Director | option exercise | 101 | $0.00 | — | 102 | May 11, 2026 |
| May 7, 2026 | Kingsley Lawrence D | Director | option exercise | 257 | $0.00 | — | 9,486 | May 11, 2026 |
| May 7, 2026 | Kingsley Lawrence D | Director | option exercise | 82 | $0.00 | — | 9,568 | May 11, 2026 |
| May 7, 2026 | Junius Daniel M | Director | option exercise | 257 | $0.00 | — | 3,561 | May 11, 2026 |
| May 7, 2026 | Hooley Joseph L | Director | option exercise | 158 | $0.00 | — | 276 | May 11, 2026 |
| Apr 30, 2026 | Hooley Joseph L | Director | award | 43 | $560.80 | $24K | 118 | May 4, 2026 |
| Mar 3, 2026 | Underberg Sharon E. | EVP, GC & Corporate Secretary | option exercise | 197 | $505.53 | $100K | 7,138 | Mar 5, 2026 |
| Mar 3, 2026 | Hunt Nimrata | Executive Vice President | open-market sale | 1,758 | $634.57 | $1M | 18,141 | Mar 5, 2026 |
| Feb 27, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | option exercise | 197 | $505.53 | $100K | 83,803 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 2,860 | $657.84 | $2M | 94,914 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 1,095 | $651.49 | $713K | 104,556 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 1,281 | $650.67 | $834K | 105,651 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | option exercise | 23,326 | $141.60 | $3M | 106,932 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 2,589 | $663.04 | $2M | 83,606 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 1,000 | $662.16 | $662K | 86,195 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 1,200 | $661.10 | $793K | 87,195 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 2,859 | $659.75 | $2M | 88,395 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 1,669 | $652.49 | $1M | 102,887 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 1,171 | $653.68 | $765K | 101,716 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 1,111 | $654.63 | $727K | 100,605 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 1,488 | $655.85 | $976K | 99,117 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 1,343 | $656.85 | $882K | 97,774 | Mar 2, 2026 |
| Feb 26, 2026 | Mazelsky Jonathan Jay | President and CEO, Director | open-market sale | 3,660 | $658.92 | $2M | 91,254 | Mar 2, 2026 |
| Feb 26, 2026 | Hunt Nimrata | Executive Vice President | open-market sale | 2,693 | $661.54 | $2M | 19,899 | Feb 27, 2026 |
| Feb 19, 2026 | Erickson Michael G | Executive Vice President | option exercise | 197 | $505.53 | $100K | 15,092 | Feb 19, 2026 |
| Feb 19, 2026 | Erickson Michael G | Executive Vice President | option exercise | 183 | $544.08 | $100K | 14,895 | Feb 19, 2026 |
| Feb 19, 2026 | Erickson Michael G | Executive Vice President | option exercise | 719 | $141.60 | $102K | 13,412 | Feb 19, 2026 |
| Feb 19, 2026 | Erickson Michael G | Executive Vice President | option exercise | 817 | $178.26 | $146K | 14,229 | Feb 19, 2026 |
| Feb 19, 2026 | Erickson Michael G | Executive Vice President | option exercise | 483 | $206.94 | $100K | 14,712 | Feb 19, 2026 |
| Feb 17, 2026 | Erickson Michael G | Executive Vice President | option exercise | 1,191 | $141.60 | $169K | 13,884 | Feb 19, 2026 |
| Feb 17, 2026 | Erickson Michael G | Executive Vice President | option exercise | 4,180 | $178.26 | $745K | 18,064 | Feb 19, 2026 |
| Feb 17, 2026 | Erickson Michael G | Executive Vice President | open-market sale | 456 | $623.76 | $284K | 17,608 | Feb 19, 2026 |
| Feb 17, 2026 | Erickson Michael G | Executive Vice President | open-market sale | 204 | $625.24 | $128K | 17,404 | Feb 19, 2026 |
| Feb 17, 2026 | Erickson Michael G | Executive Vice President | open-market sale | 1,288 | $626.26 | $807K | 16,116 | Feb 19, 2026 |
| Feb 17, 2026 | Erickson Michael G | Executive Vice President | open-market sale | 2,694 | $628.22 | $2M | 13,422 | Feb 19, 2026 |
| Feb 17, 2026 | Erickson Michael G | Executive Vice President | open-market sale | 689 | $629.09 | $433K | 12,733 | Feb 19, 2026 |
| Feb 17, 2026 | Erickson Michael G | Executive Vice President | open-market sale | 40 | $629.86 | $25K | 12,693 | Feb 19, 2026 |
| Feb 17, 2026 | Vandebroek Sophie V. | Director | option exercise | 945 | $333.90 | $316K | 2,112 | Feb 19, 2026 |
| Feb 17, 2026 | Vandebroek Sophie V. | Director | open-market sale | 945 | $628.65 | $594K | 1,167 | Feb 19, 2026 |
| Feb 17, 2026 | Vandebroek Sophie V. | Director | open-market sale | 519 | $628.56 | $326K | 648 | Feb 19, 2026 |
| Feb 14, 2026 | Underberg Sharon E. | EVP, GC & Corporate Secretary | option exercise | 173 | $0.00 | — | 6,533 | Feb 17, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Mazelsky Jonathan Jay | President and CEO, Director | Feb 27, 2026 | option exercise | 83,803 | — | $15M (13) | 0 of 13 |
| Hunt Nimrata | Executive Vice President | Mar 3, 2026 | open-market sale | 18,141 | — | $10M (6) | 0 of 6 |
| Fennell George | Executive Vice President | Jun 1, 2026 | option exercise | 10,717 | — | $7M (8) | 0 of 8 |
| Erickson Michael G | Executive Vice President | Feb 19, 2026 | option exercise | 15,092 | — | $3M (6) | 0 of 6 |
| Kingsley Lawrence D | Director | Sep 4, 2026 | option exercise | 11,771 | — | $1M (1) | 0 of 1 |
| Vandebroek Sophie V. | Director | May 7, 2026 | option exercise | 905 | — | $920K (2) | 0 of 2 |
| Lane Michael | Executive Vice President | Feb 14, 2026 | option exercise | 7,357 | — | — | — |
| Underberg Sharon E. | EVP, GC & Corporate Secretary | Mar 3, 2026 | option exercise | 7,138 | — | — | — |
| Smith Martin Alexander | Executive Vice President | Feb 14, 2026 | option exercise | 2,459 | — | — | — |
| Schreck Michael | Executive Vice President | Feb 14, 2026 | tax withholding | 3,089 | — | — | — |
| Emerson Andrew | EVP, CFO and Treasurer | Aug 20, 2026 | option exercise | 4,507 | — | — | — |
| Szostak M Anne | Director | May 7, 2026 | option exercise | 519 | — | — | — |
| Johnson Michael Perkins | Executive Vice President | Feb 14, 2026 | option exercise | 2,755 | — | — | — |
| Hooley Joseph L | Director | Jul 30, 2026 | award | 325 | — | — | — |
| Junius Daniel M | Director | May 7, 2026 | option exercise | 3,561 | — | — | — |
| Mckeon Brian P | EVP, CFO and Treasurer | Feb 14, 2025 | option exercise | 32,119 | — | — | — |
| Peacock Karen | Director | May 7, 2026 | option exercise | 102 | — | — | — |
| Essig Stuart | Director | May 6, 2025 | option exercise | 2,236 | — | — | — |
Questions
Are IDEXX Laboratories insiders buying or selling?
Over the twelve months to November 1, 2026, 6 insiders at IDEXX Laboratories sold $38M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $38M. Only open-market purchases and sales are counted.
Who sold the most IDEXX Laboratories stock in the last year?
Mazelsky Jonathan Jay (President and CEO, Director) sold $15M in 13 open-market sales over the twelve months to November 1, 2026.
Do IDEXX Laboratories executives sell under 10b5-1 plans?
0 of the 36 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on IDEXX Laboratories
- IDEXX Laboratories financial statements
- 2 tracked funds holding IDXX
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.